FindTrial
Sign In

DIFFERENT DOSES OF DEXMEDETOMIDINE ADJUVANT ADDED TO ROPIVACAINE WHICH IS A LOCAL ANESTHETIC FOR SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN PATIENTS UNDER GOING SURGERY OF ARM FOREARM AND HAND

COMPARISON OF DIFFERENT DOSES OF PERINEURAL DEXMEDETOMIDINE AS ADJUVANT TO ROPIVACAINE FOR SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN PATIENTS UNDER GOING UPPER LIMB SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020430
Enrollment
90
Registered
2019-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S598- Other specified injuries of elbowand forearm

Interventions

Intervention1: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK: three different doses dexmedetomidine will be compared when used as adjuvant in supraclavicular brachial plexus block. first dose 0.5mcg/kg second

Sponsors

ESIPGIMSR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing elective surgery of upper limb

Exclusion criteria

Exclusion criteria: Patient refusal Bleeding disorder Infection at the site block Known allergy to the study drug Peripheral neuropathy Pregnant woman History of brachial plexus injury Previous shoulder surgery

Design outcomes

Primary

MeasureTime frame
duration of analgesia (VAS)and first analgesic requirement when VAS more than 3Timepoint: 24 hours—

Secondary

MeasureTime frame
Comparison in the three group with respect to: · Onset of sensory block and motor block · Duration of sensory block and motor block · Total analgesic consumption (24hours) · Complication (if any) Timepoint: 24hours—

Countries

India

Contacts

Public ContactSnigdha

Employees State Insurance Model Hospital

dr.snigdha84@gmail.com9717022299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026